• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Equillium Plans IPO to Fund Clinical Trials for Transplant Drug

cafead

Administrator
Staff member
  • cafead   Sep 21, 2018 at 11:12: PM
via Equillium, a biotech startup developing treatments for immune system disorders—including an immune response that affects some transplant recipients—is preparing for an IPO to finance tests of its lead drug.

article source
 

<